Korro Bio, Inc.KRRONASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank63
5Y CAGR-10.2%
Year-over-Year Change
Enterprise value to sales ratio
5Y CAGR
-10.2%/yr
Long-term compound
Percentile
P63
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 15.16 | -89.5% |
| 2024 | 144.75 | - |
| 2023 | 0.00 | - |
| 2022 | 0.00 | -100.0% |
| 2021 | 78.66 | +202.1% |
| 2020 | 26.04 | +121.3% |
| 2019 | 11.76 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |